Home > Therapeutic Class > Antiobesity


Abnil is indicated: – For obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet. – To reduce the risk for weight regain after prior weight loss. – For obese patients with an initial body mass index (BMI) = 30 kg/m2 or = 27 kg/m2 in the presence of other risk factors (eg, hypertension, diabetes, dyslipidemia).